Cas no 21675-47-8 (D-Xylo-2-Hexulosonic Acid)
D-Xylo-2-Hexulosonic Acid Chemical and Physical Properties
Names and Identifiers
-
- 2-Keto-D-gulonic Acid
- 2-Keto-D-gulonic Acid Discontinued: see X750300
- 2-Keto-D-gulonic Acid Discontinued: see X750300
- D-Sorbosonic acid
- D-Xylo-2-Hexulosonic Acid
- D-xylo-Hex-2-ulosonic acid
- Q63395365
- (3R,4S,5R)-3,4,5,6-tetrahydroxy-2-oxohexanoic acid
- J-010199
- D-Xylo-hexulosonic Acid
- Gulonic acid, 2-oxo-
- 2-Keto-L-idonic acid
- rel-(3R,4S,5R)-3,4,5,6-Tetrahydroxy-2-oxohexanoic acid
- Provitamin C
- SCHEMBL5803285
- AD9F87F8-6B21-4645-830E-44DED44E8741
- VBUYCZFBVCCYFD-FLRLBIABSA-N
- xylo-2-Hexulosonic acid
- 21675-47-8
- Carboxy-xylose
- DTXSID901313625
- 16533-48-5
-
- Inchi: 1S/C6H10O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-4,7-10H,1H2,(H,12,13)/t2-,3+,4-/m1/s1
- InChI Key: VBUYCZFBVCCYFD-FLRLBIABSA-N
- SMILES: O[C@H]([C@H](C(C(=O)O)=O)O)[C@@H](CO)O
Computed Properties
- Exact Mass: 194.04265265g/mol
- Monoisotopic Mass: 194.04265265g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 5
- Hydrogen Bond Acceptor Count: 7
- Heavy Atom Count: 13
- Rotatable Bond Count: 5
- Complexity: 201
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 3
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -2.9
- Topological Polar Surface Area: 135?2
Experimental Properties
- Melting Point: >158°C (dec.)
- Solubility: DMSO, Methanol, Water
D-Xylo-2-Hexulosonic Acid Security Information
- Hazardous Material transportation number:NONH for all modes of transport
- Storage Condition:Room Temperature
D-Xylo-2-Hexulosonic Acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | PHR1708-30MG |
D-Xylo-2-Hexulosonic Acid |
21675-47-8 | 30mg |
¥6176.63 | 2025-01-14 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | Y0001024 |
D-Xylo-2-Hexulosonic Acid |
21675-47-8 | European Pharmacopoeia (EP) Reference Standard | ¥2654.27 | 2022-02-23 | ||
| TRC | X750300-100mg |
D-Xylo-2-Hexulosonic Acid |
21675-47-8 | 100mg |
105.00 | 2021-07-15 | ||
| TRC | X750300-250mg |
D-Xylo-2-Hexulosonic Acid |
21675-47-8 | 250mg |
235.00 | 2021-07-15 | ||
| TRC | X750300-500mg |
D-Xylo-2-Hexulosonic Acid |
21675-47-8 | 500mg |
425.00 | 2021-07-15 | ||
| TRC | X750300-1g |
D-Xylo-2-Hexulosonic Acid |
21675-47-8 | 1g |
800.00 | 2021-07-15 | ||
| TRC | X750300-2.5g |
D-Xylo-2-Hexulosonic Acid |
21675-47-8 | 2.5g |
1705.00 | 2021-07-15 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | Y0001024-30mg |
D-Xylo-2-Hexulosonic Acid |
21675-47-8 | 30mg |
¥1606.86 | 2025-01-16 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | PHR1708-30MG |
21675-47-8 | 30MG |
¥8575.9 | 2023-01-14 | |||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | Y0001024 |
21675-47-8 | ¥1556.7 | 2023-01-13 |
D-Xylo-2-Hexulosonic Acid Related Literature
-
1. 597. Studies on uronic acid materials. Part VII. The kinetics and mechanism of the decarboxylation of uronic acidsD. M. W. Anderson,S. Garbutt J. Chem. Soc. 1963 3204
-
Thuy Duong Vu,Ursula Eberhardt,Szániszló Sz?ke,Marizeth Groenewald,Vincent Robert Integr. Biol. 2012 4 744
-
Yifan Sun,Shaoqiu Chen,Runmin Wei,Xie Xie,Chongchong Wang,Shihao Fan,Xia Zhang,Juan Su,Jiajian Liu,Wei Jia,Xiaoyan Wang Food Funct. 2018 9 3547
Additional information on D-Xylo-2-Hexulosonic Acid
D-Xylo-2-Hexulosonic Acid (CAS No. 21675-47-8): An Overview and Recent Advances
D-Xylo-2-Hexulosonic Acid (CAS No. 21675-47-8) is a unique and versatile compound that has garnered significant attention in the fields of chemistry, biochemistry, and pharmaceutical research. This compound, also known as Xylo-2-hexulosonic acid or Xylonic acid, is a six-carbon sugar acid derived from the oxidation of D-xylose. Its structural and chemical properties make it an important molecule in various biological processes and industrial applications.
The chemical structure of D-Xylo-2-Hexulosonic Acid is characterized by a hexose backbone with a carboxylic acid group at the C-2 position. This unique configuration imparts specific reactivity and solubility properties, making it suitable for a wide range of applications. The compound is highly soluble in water, which enhances its utility in aqueous environments, such as biological systems and industrial processes.
Recent studies have highlighted the potential of D-Xylo-2-Hexulosonic Acid in various biological contexts. One notable area of research is its role in carbohydrate metabolism. As a derivative of D-xylose, D-Xylo-2-Hexulosonic Acid can be metabolized by certain microorganisms, contributing to the breakdown of complex carbohydrates. This property has implications for understanding microbial metabolism and developing new biotechnological processes for producing valuable chemicals from renewable resources.
In the pharmaceutical industry, D-Xylo-2-Hexulosonic Acid has shown promise as a potential therapeutic agent. Research has indicated that it may have anti-inflammatory and antioxidant properties, which could be beneficial in treating various diseases. For instance, studies have explored its effects on reducing oxidative stress and inflammation in cellular models, suggesting potential applications in conditions such as arthritis and neurodegenerative disorders.
The synthesis of D-Xylo-2-Hexulosonic Acid has been optimized through various methods, including enzymatic and chemical routes. Enzymatic methods involve the use of specific enzymes to catalyze the oxidation of D-xylose to D-Xylo-2-Hexulosonic Acid. These methods are generally more environmentally friendly and can produce high yields with fewer by-products. Chemical synthesis methods, on the other hand, often involve multi-step processes that can be more challenging but offer greater control over the final product's purity and yield.
One recent advancement in the synthesis of D-Xylo-2-Hexulosonic Acid involves the use of biocatalytic approaches. Researchers have developed novel biocatalysts that can efficiently convert D-xylose to D-Xylo-2-Hexulosonic Acid under mild conditions. These biocatalysts not only improve the yield but also reduce the environmental impact of the synthesis process, making it more sustainable.
In addition to its biological and pharmaceutical applications, D-Xylo-2-Hexulosonic Acid has found use in analytical chemistry. Its unique chemical properties make it a valuable reagent for various analytical techniques, such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS). These techniques are essential for characterizing complex mixtures and identifying trace amounts of compounds in biological samples.
The safety profile of D-Xylo-2-Hexulosonic Acid is another important aspect to consider. Extensive toxicological studies have shown that it is generally safe for use in both laboratory settings and industrial applications. However, as with any chemical compound, proper handling and storage procedures should be followed to ensure safety.
In conclusion, D-Xylo-2-Hexulosonic Acid (CAS No. 21675-47-8) is a multifaceted compound with significant potential in various fields. Its unique chemical structure and properties make it a valuable molecule for research and development in areas such as carbohydrate metabolism, pharmaceuticals, biotechnology, and analytical chemistry. Ongoing research continues to uncover new applications and optimize existing methods for its production and use, further solidifying its importance in the scientific community.
21675-47-8 (D-Xylo-2-Hexulosonic Acid) Related Products
- 526-98-7(2-Keto-L-gulonic Acid)
- 342385-52-8(L-Xylo-2-Hexulosonic Acid Hydrate)
- 1187-99-1(DL-4-Hydroxy-2-ketoglutarate dilithium salt)
- 669-90-9(2-Keto-d-gluconic Acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)